These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 25960998)

  • 1. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
    Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
    Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
    Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
    Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
    Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
    Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
    Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
    Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
    Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
    PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
    Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common variants in PARK loci and related genes and Parkinson's disease.
    Chung SJ; Armasu SM; Biernacka JM; Lesnick TG; Rider DN; Lincoln SJ; Ortolaza AI; Farrer MJ; Cunningham JM; Rocca WA; Maraganore DM
    Mov Disord; 2011 Feb; 26(2):280-8. PubMed ID: 21412835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
    Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
    Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
    Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
    Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
    Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
    Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
    Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
    Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNCA: major genetic modifier of age at onset of Parkinson's disease.
    Brockmann K; Schulte C; Hauser AK; Lichtner P; Huber H; Maetzler W; Berg D; Gasser T
    Mov Disord; 2013 Aug; 28(9):1217-21. PubMed ID: 23674386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Zheng J; Zang Q; Hu F; Wei H; Ma J; Xu Y
    Neurosci Lett; 2019 Jul; 706():146-150. PubMed ID: 31102707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis of the GRN  rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.
    Chen Y; Cao B; Ou R; Chen X; Zhao B; Wei Q; Wu Y; Shang HF
    Int J Neurosci; 2016 Oct; 126(10):947-54. PubMed ID: 26303052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
    Das G; Misra AK; Das SK; Ray K; Ray J
    Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.